The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4- one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
本发明涉及含有至少一种
噻唑烷-4-酮衍
生物的药物组合物,用于预防或治疗与活化免疫系统相关的疾病。此外,本发明还涉及新型
噻唑烷-4-酮衍
生物,特别是用作药物活性化合物。所述化合物尤其还可用作
免疫抑制剂。